In this article, we will discuss the 15 Most Promising Stocks Under $100 to Buy.

On March 12, Roger Ferguson, former Fed Vice Chair, joined ‘Closing Bell’ on CNBC to discuss what to expect from the Federal Reserve next week. Ferguson shared his expectation for a pause in interest rate hikes, aligning with the CME FedWatch tool’s current investor sentiment. He outlined three primary reasons for this view: the Fed’s established wait-and-see stance, incoming data that has been important but not decisive, and a CPI report that met expectations. He described the labor market data as moving sideways, with recent reports showing conflicting signals of both strength and weakness, which reinforced the likelihood of the Fed remaining on the sidelines.

When challenged on the potential for rising inflation due to a core CPI of 2.5% and an impending oil shock, Ferguson acknowledged that core PCE could be closer to 2.9% and that energy prices will likely cause a spike in headline inflation. He explained that Fed policymakers often view an oil spike as stagflationary; it simultaneously raises inflation temporarily and drains consumer liquidity, which can lead to economic stagnation. The critical determination for the Fed, according to Ferguson, is whether this inflation is a temporary reaction to an oil shock or if it begins to embed into long-term expectations, which would eventually force a tightening of monetary policy.

Our Methodology

We used screeners to identify stocks that are trading below $100 per share and had an average upside potential of at least 30%. We limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds.

Note: All data was sourced on March 17. 

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).

15 Most Promising Stocks Under $100 to Buy

15. GeneDx Holdings Corp. (NASDAQ:WGS)

GeneDx Holdings Corp. (NASDAQ:WGS) is one of the most promising stocks under $100 to buy. On March 10, GeneDx and Zevra Therapeutics (NASDAQ:ZVRA) announced a new partnership to launch a sponsored genetic testing program for NPC (Niemann-Pick disease type C). This aims to expand access to GeneDx’s ExomeDx test for patients in the US who are suspected of having this rare, inherited condition. By providing high-quality exome sequencing at no charge to eligible patients, the program seeks to help clinicians confirm diagnoses more quickly and guide informed clinical decision-making.

The program addresses the challenges of NPC, which is a progressive neurodegenerative disorder caused by mutations in the NPC1 and NPC2 genes. Because the disease often presents with symptoms that overlap with other metabolic or neurological conditions, diagnosis is frequently delayed. This collaboration focuses on removing barriers to genomic testing, allowing healthcare providers to receive results in as little as 3 weeks. Identifying patients earlier is considered a critical step in managing the disease and ensuring access to appropriate therapies as they emerge.

De-identified data from the testing program will be integrated into GeneDx Infinity, which is a large rare-disease genomic dataset. This integration is intended to help biopharmaceutical partners better understand disease biology and accelerate the journey from diagnosis to treatment. Zevra Therapeutics is providing financial support for the program, reflecting a joint commitment to using genomic insights to improve outcomes for individuals and families affected by NPC.

GeneDx Holdings Corp. (NASDAQ:WGS) is a genomics company in the healthcare industry. It provides genetic testing services and provides pediatric & rare disease diagnostics.

14. Booz Allen Hamilton Holding Corporation (NYSE:BAH)

Booz Allen Hamilton Holding Corporation (NYSE:BAH) is one of the most promising stocks under $100 to buy. On March 11, Booz Allen Hamilton announced an investment in Hadean, which is a UK-based tech firm specializing in AI-powered digital wargaming and command and control capabilities. This move by Booz Allen Ventures marks the firm’s first international investment and is designed to help Hadean establish a presence in the US.

The collaboration builds on a two-year partnership aimed at modernizing military training and mission rehearsals for the US, NATO, and other Western allies through advanced synthetic environments. The partnership integrates Hadean’s simulation platform with Booz Allen Hamilton Holding Corporation’s (NYSE:BAH) role as a leading provider of AI to the federal government to deliver joint solutions involving agentic and spatial computing.

These technologies are intended to revolutionize operational readiness by replacing legacy systems with scalable, secure, and deployable capabilities. While the primary focus remains on defense and the warfighter, the technology has potential applications across the civil, intelligence, and national security sectors to provide a decisive edge in complex environments.

Booz Allen Hamilton Holding Corporation (NYSE:BAH) is a consulting services company that provides technology solutions using AI and cyber technologies for the government and commercial customers.

13. SEI Investments Company (NYSE:SEIC)

SEI Investments Company (NYSE:SEIC) is one of the most promising stocks under $100 to buy. On March 9, SEI announced a collaboration with IBM (NYSE:IBM) to accelerate its enterprise transformation through the integration of agentic AI and automation. This initiative involves a comprehensive, data-driven review of SEI’s operational systems and workflows to identify opportunities for process redesign and modernization. By building a data-enabled operating foundation, the company aims to improve productivity and streamline client interactions.

The partnership focuses on deploying AI to automate routine tasks, allowing teams to shift their focus toward higher-value, relationship-driven activities. Making automation the engine of growth will enable the company to innovate faster and scale with greater confidence. This shift is intended to elevate service quality and strengthen client trust while creating new opportunities for professional development within the organization’s workforce.

IBM Consulting will work closely with SEI’s subject matter experts to embed agentic AI into day-to-day operations using the IBM Enterprise Advantage platform. This platform serves as a strategic enabler to transform the operating model and enhance decision-making capabilities. By combining SEI’s industry knowledge with IBM’s expertise in process intelligence, the collaboration seeks to unlock new levels of efficiency and further differentiate SEI Investments Company (NYSE:SEIC) within the highly regulated financial services market.

SEI Investments Company (NYSE:SEIC) is an asset management company that provides wealth management, retirement & investment solutions, asset administration, investment processing outsourcing solutions, financial services, and investment advisory services.

12. Allegiant Travel Company (NASDAQ:ALGT)

Allegiant Travel Company (NASDAQ:ALGT)  is one of the most promising stocks under $100 to buy. On March 16, Allegiant Travel Company and Sun Country Airlines (NASDAQ:SNCY) announced the early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act regarding their proposed merger. This development signifies that the companies have received US antitrust clearance from the Department of Justice, marking a major milestone in the acquisition process.

The move brings the two leisure-focused carriers closer to combining their operations and expanding their collective service offerings. While antitrust clearance has been secured, the transaction remains subject to several customary closing conditions before it can be finalized. These include approval from the US Department of Transportation regarding an interim exemption application, as well as formal approval from the shareholders of both Allegiant and Sun Country. Following these regulatory and corporate steps, the companies currently expect the deal to close during Q2 or Q3 2026.

Leadership from Allegiant Travel Company (NASDAQ:ALGT) expressed confidence that the combination will provide significant benefits to customers, employees, and the communities served by both airlines. By joining forces, the entities aim to create a more robust leisure travel network with increased options for passengers. Additionally, the merger is intended to drive long-term value creation for shareholders by using the strengths of the two specialized carriers within the broader aviation market.

Allegiant Travel Company (NASDAQ:ALGT) is an airline company that provides travel and leisure services & products for underserved cities in the US. It also offers third-party travel products like hotel rooms, rental cars, and travel insurance.

11. Kymera Therapeutics Inc. (NASDAQ:KYMR)

Kymera Therapeutics Inc. (NASDAQ:KYMR) is one of the most promising stocks under $100 to buy. On March 10, Kymera Therapeutics announced that data from its Phase 1b clinical trial of KT-621 will be featured in a late-breaking oral presentation at the American Academy of Dermatology 2026 Annual Meeting. The study, known as the BroADen trial, evaluated the clinical activity and safety of the drug in patients with moderate-to-severe atopic dermatitis. The presentation is scheduled for March 28 in Denver, providing an opportunity for the company to share results with the medical communities.

The investigational drug, KT-621, represents a first-in-class, once-daily oral medicine designed to target and degrade STAT6. This specific protein is a key driver of Type 2 inflammation, which is responsible for various chronic immuno-inflammatory conditions. By selectively addressing the signaling pathways involved in these diseases, Kymera Therapeutics Inc. (NASDAQ:KYMR) aims to provide a novel oral treatment option for the millions of people worldwide affected by atopic dermatitis and related inflammatory disorders.

Currently, KT-621 is being further evaluated in parallel Phase 2b clinical trials focusing on both atopic dermatitis and asthma. Kymera’s leadership highlighted the significance of being selected for a late-breaking session, noting that the upcoming data release is a critical step in their effort to advance oral small-molecule degraders.

Kymera Therapeutics Inc. (NASDAQ:KYMR) discovers and develops small-molecule therapeutics that selectively degrade disease-causing proteins by using the body’s natural protein degradation system.

10. Commvault Systems Inc. (NASDAQ:CVLT)

Commvault Systems Inc. (NASDAQ:CVLT) is one of the most promising stocks under $100 to buy. On March 5, Commvault and CloudSEK announced an integration to help enterprises defend against identity-based cyberattacks resulting from stolen or exposed credentials. By combining CloudSEK’s predictive threat intelligence with Commvault’s Active Directory protection offerings, the partnership aims to address a critical security gap where compromised credentials are involved in nearly 80% of all breaches.

This collaboration is particularly focused on combating the collapse in time between credential exposure on the dark web and active exploitation by AI-driven adversaries. The integration works by correlating external signals from dark web marketplaces and underground forums with internal identity telemetry. This allows organizations to identify exposed accounts early and take immediate remedial actions, such as locking compromised credentials or rolling back malicious changes to Active Directory.

By scoring and prioritizing risks across internal and public sources, the system provides security teams with clear guidance to neutralize threats before they can escalate into ransomware deployment or data exfiltration. Scheduled for release this summer, the integration will be available at no additional cost to customers using Commvault Systems Inc.’s (NASDAQ:CVLT) Active Directory Vulnerability Assessments and Advanced Audit solutions.

Commvault Systems Inc. (NASDAQ:CVLT) is a technology company that offers a cyber resilience platform for protecting and recovering data & cloud-native applications internationally.

9. CoreWeave Inc. (NASDAQ:CRWV)

CoreWeave Inc. (NASDAQ:CRWV) is one of the most promising stocks under $100 to buy. On March 16, CoreWeave announced a significant expansion of its AI-native cloud platform at the NVIDIA GTC conference, introducing the general availability of NVIDIA HGX B300 instances. This new generation of hardware, part of the Blackwell Ultra platform, features a 50% increase in memory and doubled node-to-node bandwidth to support long-context inference and models with over 100 billion parameters.

To maintain sustained peak performance for these mission-critical workloads, every server is managed by state-of-the-art liquid cooling technology to prevent thermal throttling. The platform expansion is specifically designed to support the industry shift from large-scale model training to the deployment of autonomous agents and physical AI.

Through a partnership with Weights & Biases, CoreWeave is introducing environment-free reinforcement learning and advanced production evaluations. These tools allow agents to learn through continual on-the-job training rather than costly simulated environments, while automated scoring and failure detection help researchers refine models based on real-world user interactions. Looking ahead, CoreWeave Inc. (NASDAQ:CRWV) expects to be among the first cloud providers to deploy the NVIDIA Vera Rubin NVL72 platform in H2 2026.

CoreWeave Inc. (NASDAQ:CRWV) is a cloud infrastructure company that provides the CoreWeave Cloud platform. This platform comprises proprietary software and cloud services for the automation and efficiency needed for complex AI infrastructure at scale.

8. PennyMac Financial Services Inc. (NYSE:PFSI)

PennyMac Financial Services Inc. (NYSE:PFSI) is one of the most promising stocks under $100 to buy. On March 10, PennyMac Financial Services launched a suite of non-qualified mortgage (Non-QM) products within its third-party origination division. These new offerings are designed to assist self-employed individuals, entrepreneurs, and business owners who may not meet traditional lending criteria.

By providing flexible qualification paths, the company aims to help its partners address complex borrower scenarios and expand their reach in the growing Non-QM market. The product suite includes several specialized tools tailored to diverse financial situations. For real estate investors, the Debt Service Coverage Ratio option qualifies loans based on property cash flow rather than personal income.

Other programs include bank statement-based income calculations for those without standard tax returns, and asset depletion models for retirees or high-net-worth individuals. Additional options, such as 1099 and written verification of employment programs, are also available to support various wealth-building methods. These products are now live and available to all approved partners through the company’s TPO channel.

PennyMac Financial Services Inc. (NYSE:PFSI) is a mortgage finance company that operates through two segments: Production and Servicing.

7. Guardant Health Inc. (NASDAQ:GH)

Guardant Health Inc. (NASDAQ:GH) is one of the most promising stocks under $100 to buy. On March 16, Guardant Health announced the launch of its Shield multi-cancer detection/MCD test in several Asian markets through a first-of-its-kind partnership with Manulife. This methylation-based blood test is designed to detect ten common types of cancer (including lung, breast, colorectal, and liver) in individuals aged 45 or older who are at typical risk.

Starting in April, eligible Manulife customers in Hong Kong, Singapore, and the Philippines will be the first in the region to gain access to this screening technology. The collaboration aims to address significant unmet health needs in Asia, where cancer remains a leading cause of death, and early detection is vital for survivorship.

By requiring only a simple blood draw, the Shield MCD test seeks to increase screening participation rates and identify malignancies at earlier, more treatable stages. In the US, the technology has already received Breakthrough Device Designation from the FDA based on its performance in predicting the presence and origin of cancer tissue. This move marks a major milestone in Guardant Health Inc.’s (NASDAQ:GH) global expansion of precision oncology tools.

Guardant Health Inc. (NASDAQ:GH) is a precision oncology company in the healthcare industry. It provides blood & tissue tests and data sets; particularly the Guardant360 CDx, Guardant360 Liquid, Guardant Reveal, and Guardant360 Tissue test.

6. AECOM (NYSE:ACM)

AECOM (NYSE:ACM) is one of the most promising stocks under $100 to buy. On March 17, AECOM announced it had been selected to provide design and technical services as part of the ILIOS consortium for the first phase of the £200 million Spherical Tokamak for Energy Production/STEP program. Appointed by UK Fusion Energy, the consortium will oversee the initial 3-year tranche of this flagship initiative aimed at building a world-leading prototype fusion power plant in Nottinghamshire.

This project represents a significant step in the UK government’s strategy to transition to low-carbon energy, with the broader program offering future opportunities valued at up to £10 billion. The primary goal of the STEP program is to deliver a commercially viable fusion power plant at the West Burton site by 2040.

The consortium, known as ILIOS, includes specialists from Kier Nuvia, Turner & Townsend, and AL_A, who will work alongside the UK Atomic Energy Authority. The responsibilities encompass the design and construction of all site infrastructure and facilities, ensuring the project meets complex scientific and high-hazard engineering standards while managing the intricate supply chain and program planning required for such a pioneering energy source. The project is expected to generate substantial socioeconomic benefits, including the creation of up to 8,000 jobs during the peak of construction.

AECOM (NYSE:ACM) is an engineering & construction company that offers professional infrastructure consulting services for governments, businesses, and organizations through the Americas, International, and AECOM Capital segments.

Click to continue reading and see the 5 Most Promising Stocks Under $100 to Buy.

Disclosure: None. None. Follow Insider Monkey on Google News.